Does Shell Shock Go Away? A Look at PTSD Recovery

PTSD, the modern name for what earlier generations called shell shock, does go away for a large share of people who develop it. A meta-analysis of long-term studies found that roughly 44 percent of people diagnosed with PTSD no longer met the criteria at follow-up, even without targeted treatment. But that average conceals enormous variation, with individual remission rates ranging from as low as 8 percent to as high as 89 percent depending on the type of trauma, how quickly someone was assessed, and what kind of support they had. Recovery is real and common, but it is neither guaranteed nor uniform.

Same Condition, Different Names

The symptoms that define PTSD today, including flashbacks, hypervigilance, emotional numbing, and nightmares, have been documented in soldiers for centuries under labels like “soldier’s heart,” “shell shock,” and “war neurosis.”¹ Shell shock specifically referred to the constellation of symptoms observed in World War I troops, which physicians at the time attributed to the physical concussive force of artillery blasts. Over subsequent decades, clinicians recognized that the same syndrome appeared in people who had never been near an explosion, and the understanding shifted toward psychological trauma as the root cause.² When PTSD entered the official diagnostic manual in 1980, it unified these earlier concepts under one diagnosis applicable to any sufficiently traumatic event, not just combat. So when people ask whether shell shock goes away, they are really asking about PTSD recovery, and the evidence on that question is extensive.

How Often People Recover Without Treatment

The fastest natural recovery happens in the first few months. A meta-analysis tracking PTSD rates after trauma found that over a quarter of people met the criteria for PTSD one month after their traumatic event, and that proportion dropped by about a third between the one-month and three-month marks.³ After three months, improvement continued but at a much slower pace, and any further declines in prevalence showed up only over longer time windows.

When researchers looked specifically at people who already had a PTSD diagnosis and followed them long-term, the overall remission rate was about 44 percent. Timing mattered: people assessed within five months of the trauma had a remission rate of roughly 52 percent, while those first assessed later than five months remitted at about 37 percent.⁴ The type of trauma mattered even more. PTSD following natural disasters had the highest remission, around 60 percent, while PTSD related to physical illness had the lowest, around 31 percent. These are people recovering on their own or with whatever informal support they happened to have, not in clinical trials of specific therapies.

The takeaway is that PTSD is not a life sentence by default. A substantial number of people recover naturally, especially in the first year. But “substantial” is not “most,” and by six months the window of rapid natural recovery has largely closed for those who still have symptoms.

What Shapes the Odds of Recovery

Several factors tilt the scales. One of the most studied is whether the person is a civilian or a member of the military. A meta-analysis comparing treatment outcomes found that military populations showed a smaller response to first-line psychotherapies than civilians.⁵ This gap seems to reflect real differences in trauma exposure rather than some flaw in military patients. Service members are more likely to have experienced repeated traumas over extended deployments, and their combat-related PTSD often sits alongside traumatic brain injury, moral injury, and the challenges of reintegrating into civilian life. One study of a brief therapy found that both military and civilian patients improved meaningfully, but civilians showed somewhat greater reductions in intrusive and numbing symptoms during follow-up.⁶

Social support is another powerful influence, and it works in both directions. People with stronger social networks tend to recover faster, and that pattern holds whether the support comes from friends, family, or community. A study tracking recently traumatized adults found that increases in social support, particularly from friends, accelerated PTSD recovery across the entire post-trauma year.⁷ But the relationship runs both ways: more severe PTSD eroded social support over time, creating a feedback loop where the people who need connection the most are the ones losing it. Research on co-occurring substance use and PTSD confirmed the same pattern: higher social support predicted bigger drops in both PTSD symptoms and substance use during treatment.⁸

Sleep quality also plays into recovery. A study examining how sleep architecture relates to trauma memory processing found that disrupted deep sleep and altered rapid eye movement patterns after trauma exposure were linked to less improvement in PTSD symptoms over time.⁹ Healthy sleep appears to help the brain process and integrate traumatic memories, while the fragmented, nightmare-heavy sleep common in PTSD may interfere with that process.

What Changes in the Brain During Recovery

PTSD leaves visible marks on the brain, particularly in the hippocampus, a region involved in memory and distinguishing past dangers from present safety. People with PTSD consistently show reduced hippocampal volume compared to healthy controls. The encouraging finding is that this shrinkage appears reversible. Studies have shown that antidepressant treatment and changes in environment can increase hippocampal volume in people with PTSD.¹⁰

More recent work has sharpened this picture. A study using real-time functional MRI neurofeedback training found that the experimental group of PTSD patients showed significant hippocampal volume increases in the specific sub-region that had been most reduced at baseline, while a control group actually showed further volume loss in the same area.¹¹ The implication is striking: the brain’s structural damage from PTSD is not permanent but can be actively reversed with the right intervention.

The relationship between brain structure and treatment response is not straightforward, though. Data from two clinical trials found that patients who started treatment with larger hippocampal volume showed greater symptom improvement as their hippocampal volume increased further during therapy.¹² In other words, starting with more hippocampal “reserve” seemed to predict a better treatment response. This might partly explain why early intervention works better: the longer PTSD persists and the hippocampus remains reduced, the harder recovery becomes.

Beyond brain structure, the body’s stress hormone and immune systems also shift with recovery. Research on neuroendocrine and immune markers in PTSD suggests that the biological disruption caused by trauma may become more entrenched over time but can be reversed with effective treatment.¹³ The stress-response system does not stay permanently broken; it is capable of recalibrating.

Beyond Talk Therapy

The established first-line treatments for PTSD are trauma-focused psychotherapies such as prolonged exposure and cognitive processing therapy. These work for many people, but a sizable minority either does not respond, drops out, or cannot access them. That gap has driven interest in newer approaches that work through different mechanisms.

MDMA-Assisted Therapy

One of the most discussed emerging treatments pairs the drug MDMA with psychotherapy sessions. In a phase 3 clinical trial, about 71 percent of participants who received MDMA-assisted therapy no longer met the diagnostic criteria for PTSD by the end of the study, compared with roughly 48 percent in the group receiving therapy with a placebo.¹⁴ Nearly half of the MDMA group met full remission criteria, meaning their symptoms were minimal, versus about a fifth of the placebo group.

Durability has been a key question. A long-term follow-up study of people who had received MDMA-assisted therapy, some of whom had previously been unresponsive to other treatments, found that symptom improvements held steady an average of about 45 months later, with scores essentially unchanged from post-treatment levels.^{15 16} Two participants did relapse, and the regulatory path for this treatment has been rocky, with the U.S. Food and Drug Administration declining to approve it in its initial application over concerns about trial design and safety monitoring. But for treatment-resistant cases, the results remain among the most dramatic in the field.

Stellate Ganglion Block

A completely different approach targets the sympathetic nervous system directly. The stellate ganglion block, or SGB, is a nerve block injection in the neck that has been used in pain medicine for nearly a century. A randomized clinical trial found that two SGB injections produced an average symptom reduction roughly twice as large as a sham injection, with the active treatment group improving by about 13 points on a standard PTSD scale versus about 6 points for placebo.¹⁷ The proposed mechanism is that the injection temporarily resets the overactive fight-or-flight signaling that keeps PTSD patients in a state of constant alarm.¹⁸ It is not a standalone cure, but for people who are too activated to engage with psychotherapy, it may serve as a bridge that makes the harder work of trauma processing possible.

Repetitive Transcranial Magnetic Stimulation

Transcranial magnetic stimulation uses magnetic pulses to stimulate or calm specific brain regions through the skull. A meta-analysis of eight studies found that repetitive TMS produced a large overall reduction in PTSD symptoms, and follow-up data showed no significant difference between symptom levels at the end of treatment and at later follow-up, suggesting the effects held.¹⁹ A separate systematic review and meta-analysis confirmed durable symptom reduction lasting two to four weeks after stimulation ended.²⁰ The evidence is promising but still based on fairly small samples, and researchers have noted that more large-scale studies are needed.²¹

Treatment-Resistant PTSD

For a subset of people, PTSD proves stubbornly persistent despite multiple treatment attempts. A systematic review examining how researchers define “treatment-resistant PTSD” found substantial variation across 55 studies, with no consensus definition in use.²² Some studies required failure of two evidence-based treatments, others required only one, and the types of treatment counted differed. This inconsistency makes it hard to pin down exactly how many people have truly treatment-resistant PTSD versus how many simply have not yet received the right treatment or an adequate course of one. What is clear is that a meaningful minority of patients, particularly those with complex trauma histories, co-occurring disorders like substance use or traumatic brain injury, or delayed access to care, do not respond to standard approaches and represent the greatest challenge in the field.

When Symptoms Return Decades Later

An unsettling pattern appears among some aging combat veterans. Researchers have identified a phenomenon called late-onset stress symptomatology, or LOSS, in veterans who functioned well throughout their working years with no history of chronic stress disorders but began experiencing increased combat-related thoughts, feelings, and memories as they moved into retirement and old age.²³ This is not the same as PTSD, though the two overlap. LOSS is more strongly tied to retirement-related concerns and less strongly associated with the depression, anxiety, and diminished sense of control that characterize full PTSD.²⁴

The pattern makes intuitive sense. During working years, the structure and demands of a career can keep traumatic memories at bay. Retirement removes that structure, and aging itself brings losses like declining health, the deaths of peers, and a natural tendency toward life review that can pull old memories to the surface. For someone asking whether shell shock ever truly goes away, this is an important caveat: even people who appeared fully recovered for decades can find trauma-related distress resurfacing under new life circumstances. That does not mean they are back to square one. LOSS tends to be less severe than full PTSD, and many veterans manage it successfully with peer support, counseling, or simply understanding what is happening to them.

Recovery at the Molecular Level

One of the more fascinating frontiers involves epigenetics, the study of how genes get switched on or off without changes to the DNA sequence itself. A study of military veterans found that successful PTSD treatment was accompanied by significant changes in DNA methylation at specific gene regions, including one gene called ZFP57 that appeared to be involved in both the development and resolution of deployment-related PTSD.²⁵ This suggests that recovery is not just psychological but leaves a measurable molecular signature.

The picture is more complicated than a simple “undo” button, though. A study of former child soldiers who received narrative exposure therapy found that the specific DNA methylation sites linked to trauma-related symptoms were largely not the same sites that changed with treatment.²⁶ Rather than reversing the original epigenetic changes, treatment seemed to work by activating alternative regulatory pathways. The trauma leaves its molecular mark; recovery does not erase that mark so much as build new ones that compensate for it. This fits with what many trauma survivors report subjectively: recovery does not mean forgetting or returning to the person they were before. It means developing new ways of managing what happened.

Post-Traumatic Growth

An idea that sometimes surprises people is that trauma can produce positive psychological changes alongside or even because of the suffering it causes. Researchers call this post-traumatic growth, and it includes things like deepened relationships, a revised sense of what matters in life, greater appreciation for being alive, and a feeling of personal strength forged through adversity. A meta-analysis examining the relationship between PTSD symptoms and post-traumatic growth found that the two can co-occur: people reporting more post-traumatic distress also tended to report more growth.²⁷

This is worth lingering on because it challenges a binary view of recovery. Growth does not replace the pain or mean the trauma was “worth it.” It means that the struggle to make sense of a devastating experience can, for some people, produce genuine positive changes that would not have occurred otherwise. It also means that asking “does PTSD go away?” may be the wrong framing for some survivors, whose trajectory looks less like a return to baseline and more like arriving somewhere different altogether.

PTSD and the Risk of Dementia

One strong reason to take PTSD recovery seriously is its connection to long-term brain health. A large study of U.S. veterans found that those with PTSD had a seven-year dementia rate of about 11 percent, compared with roughly 7 percent among veterans without PTSD. Even after adjusting for factors like head injury, substance abuse, and depression, veterans with PTSD were still about 77 percent more likely to develop dementia.²⁸ The study cannot prove that PTSD caused the dementia, but the association held up even when researchers excluded the most obvious confounding conditions. Chronic stress, disrupted sleep, elevated inflammation, and the hippocampal volume reduction discussed earlier all offer plausible pathways linking untreated PTSD to later cognitive decline. Whether successfully treating PTSD reduces this long-term dementia risk is still an open question, but the finding adds urgency to the broader case for early, effective treatment. Recovery from PTSD is not only about quality of life in the present; it may matter for the health of the brain decades down the line.